X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (34) 34
hematology (31) 31
chronic myeloid leukemia (26) 26
index medicus (25) 25
adult (22) 22
middle aged (22) 22
female (21) 21
male (21) 21
aged (17) 17
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (16) 16
oncology (16) 16
treatment outcome (15) 15
chronic myelogenous leukemia (14) 14
imatinib mesylate (13) 13
leukemia (13) 13
imatinib (12) 12
antineoplastic agents - therapeutic use (11) 11
dasatinib (11) 11
adolescent (9) 9
aged, 80 and over (9) 9
care and treatment (9) 9
nilotinib (9) 9
pyrimidines - therapeutic use (9) 9
leukemia, myelogenous, chronic, bcr-abl positive - mortality (8) 8
myeloid leukemia (8) 8
piperazines - therapeutic use (8) 8
prognosis (8) 8
analysis (7) 7
antimitotic agents (7) 7
antineoplastic agents (7) 7
leukemia, myelogenous, chronic, bcr-abl positive - therapy (7) 7
medicine & public health (7) 7
protein kinase inhibitors - therapeutic use (7) 7
survival analysis (7) 7
therapy (7) 7
time factors (7) 7
tyrosine (7) 7
tyrosine kinase inhibitors (7) 7
young adult (7) 7
cancer (6) 6
cml (6) 6
cytogenetic response (6) 6
disease-free survival (6) 6
hemic and lymphatic diseases (6) 6
interferon-alpha - therapeutic use (6) 6
medical and health sciences (6) 6
medicin och hälsovetenskap (6) 6
pyrimidines - adverse effects (6) 6
retrospective studies (6) 6
antineoplastic agents - administration & dosage (5) 5
benzamides - therapeutic use (5) 5
cells (5) 5
chronic-phase (5) 5
clinical medicine (5) 5
follow-up studies (5) 5
fusion proteins, bcr-abl - genetics (5) 5
leukemia, myelogenous, chronic, bcr-abl positive - genetics (5) 5
leukemia, myeloid, chronic-phase - drug therapy (5) 5
phenols (5) 5
pyrimidines - administration & dosage (5) 5
survival (5) 5
benzamides (4) 4
chronic myeloid-leukemia (4) 4
cytogenetics (4) 4
drug therapy (4) 4
follow-up (4) 4
health aspects (4) 4
hematologi (4) 4
in-vitro (4) 4
interferon alpha (4) 4
interferon-alpha (4) 4
internal medicine (4) 4
intolerance (4) 4
klinisk medicin (4) 4
leukemia, myelogenous, chronic, bcr-abl positive - blood (4) 4
management (4) 4
mice (4) 4
molecular response (4) 4
patients (4) 4
recombinant proteins (4) 4
recommendations (4) 4
risk factors (4) 4
thiazoles - therapeutic use (4) 4
transplantation (4) 4
abridged index medicus (3) 3
animals (3) 3
arterial occlusive disease (3) 3
bcr protein (3) 3
bosutinib (3) 3
cancer research (3) 3
cardiovascular risk factors (3) 3
chemotherapy (3) 3
chronic phase (3) 3
clinical trials (3) 3
comprehensive treatment (3) 3
consensus meeting (3) 3
diagnosed chronic-phase (3) 3
drug resistance, neoplasm (3) 3
erythema nodosum (3) 3
europe (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Hematology, ISSN 0361-8609, 04/2015, Volume 90, Issue 4, pp. E66 - E72
Rare but serious cardiovascular and pulmonary adverse events ( AEs ) have been reported in patients with chronic myeloid leukemia treated with BCR‐ABL... 
CHRONIC PHASE | DASATINIB TREATMENT | NILOTINIB THERAPY | PLEURAL EFFUSION | VASCULAR EVENTS | DATABASES | ARTERIAL OCCLUSIVE DISEASE | HYPERTENSION | HEMATOLOGY | IMATINIB MESYLATE | CHRONIC MYELOID-LEUKEMIA | Piperazines - administration & dosage | Lung Diseases - chemically induced | United States | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Thiazoles - administration & dosage | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Thiazoles - therapeutic use | Thiazoles - adverse effects | Young Adult | Benzamides - administration & dosage | Benzamides - therapeutic use | Antineoplastic Agents - adverse effects | Cardiovascular Diseases - epidemiology | Product Surveillance, Postmarketing | Adult | Benzamides - adverse effects | United States Food and Drug Administration | Databases, Factual | Dasatinib | Adverse Drug Reaction Reporting Systems | Pyrimidines - administration & dosage | Logistic Models | Piperazines - therapeutic use | Imatinib Mesylate | Piperazines - adverse effects | Pyrimidines - therapeutic use | Adolescent | Fusion Proteins, bcr-abl - antagonists & inhibitors | Pyrimidines - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Aged | Cardiovascular Diseases - chemically induced | Lung Diseases - epidemiology | Care and treatment | Data mining | Drug approval | Analysis | Leukemia
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 06/1998, Volume 90, Issue 11, pp. 850 - 858
Background: Interferon alfa is a conservative and widely used alternative to bone marrow transplantation in treatment of patients with early chronic myeloid... 
CHRONIC MYELOGENOUS LEUKEMIA | CYTOSINE-ARABINOSIDE | CHRONIC GRANULOCYTIC-LEUKEMIA | MULTICENTER | CHRONIC-PHASE | ONCOLOGY | DISCRIMINATION | HYDROXYUREA | CYTOGENETIC RESPONSE | ALPHA | BUSULFAN | Medical research | Interferon | Drug therapy | Leukemia
Journal Article
Medicina Clinica, ISSN 0025-7753, 06/2016, Volume 146, Issue 12, pp. 561.e1 - 561.e8
Introduction and objectives The second generation tyrosine kinase inhibitors (TKI, dasatinib and nilotinib) used in chronic myeloid leukemia (CML) treatment... 
Comprehensive treatment | Cardiovascular risk factors | Consensus meeting | Chronic myeloid leukemia
Journal Article
Blood, ISSN 0006-4971, 08/2013, Volume 122, Issue 6, pp. 872 - 884
Journal Article
European Journal of Haematology, ISSN 0902-4441, 10/2014, Volume 93, Issue 4, pp. 309 - 319
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal disease. To date, many reviews and series have been described. We report the experience of our... 
secondary cancer | paroxysmal nocturnal hemoglobinuria | eculizumab | thrombosis | Original | liver transplantation
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0181366
Journal Article
Blood, ISSN 0006-4971, 06/2012, Volume 119, Issue 25, pp. 5963 - 5971
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2012, Volume 7, Issue 2, p. e32451
Chromosomal translocations in tumors frequently produce fusion genes coding for chimeric proteins with a key role in oncogenesis. Recent reports described a... 
CHRONIC MYELOGENOUS LEUKEMIA | IN-VITRO | MYELOPROLIFERATIVE DISORDERS | PHILADELPHIA-CHROMOSOME | ACUTE LYMPHOBLASTIC-LEUKEMIA | BIOLOGY | CELL LINES | RESIDUAL DISEASE | FUSES BCR | CHRONIC MYELOID-LEUKEMIA | SIGNAL TRANSDUCER | Protein Structure, Tertiary | Cell Line | Oncogene Proteins, Fusion - metabolism | Phosphorylation | Proto-Oncogene Proteins c-bcr - metabolism | Humans | Middle Aged | Real-Time Polymerase Chain Reaction - methods | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Animals | Mice, Nude | Janus Kinase 2 - metabolism | Reverse Transcriptase Polymerase Chain Reaction - methods | HEK293 Cells | Female | Mice | bcl-X Protein - metabolism | Apoptosis | Proteins | Tyrosine | Oligomers | Analysis | Genes | Phenols | B cells | Gene expression | Blood | Cell activation | Bcl-x protein | Janus kinase 2 | Fluorescence in situ hybridization | Bone marrow | Fusion protein | Chromosomes | Autografts | Cytokines | Medical treatment | Glycoproteins | Lymphatic leukemia | Survival | Polymerase chain reaction | Molecular modelling | Inhibitors | Stem cells | Nuclei (cytology) | Lymphomas | Gene therapy | Acute myeloid leukemia | BCR protein | Cell proliferation | Deregulation | Leukemia | Fluorescence | Transplantation | Kinases | Interleukin 3 | Transgenic animals | Translocation | Acute lymphatic leukemia | Oligomerization | Cell survival | Hematology | Myeloid leukemia | Minimal residual disease | Abl protein | Progenitor cells | Hemopoiesis | Chromosome translocations | Cells (biology) | Molecular biology | Cytoplasm | Tumors
Journal Article